The Catalyst

Most Recent Posts

05.12.11

Battelle, the world's largest independent research organization, is out with a new report on the economic impact of the human genome project. The headline from the report is that the "$3.8 billion investment in the Human Genome Project drove $796 billion in economic impact creating 310,000 jobs and launching the genomic revolution."

The four main conclusions reached in the Battelle study are:

05.11.11

CBS Morning News ran a good piece on the growing problem of counterfeit drugs. It's worth taking a look at. And for more information on the counterfeit drugs epidemic, visit http://www.phrma.org/issues/counterfeit-drugs.

05.11.11 | By Kate Connors

Today was the launch of the Script Your Future campaign, an effort to encourage patients living with chronic diseases to better manage their conditions by taking their medicines as directed.

According to the campaign's Web site, "Understanding your condition and taking your medicine correctly are important steps toward a longer, healthier life. This campaign can help you with tools to manage your medicines."

05.11.11

A piece over at Everyday Health has some good, common sense tips for women concerned about heart disease.

05.09.11 | By Kate Connors

Last Wednesday, I mentioned a Boston Globe article about biopharmaceutical research companies and the emphasis on studying medicines in specific populations, for rare conditions, and more.

In that post, I provided some examples of PhRMA's Medicines in Development Reports, which are a wealth of just this sort of information.

05.06.11

I've got a couple of more good pieces I want to pass along today.

05.06.11 | By Kate Connors

Tonight, the Society for Women's Health Research is hosting an event to raise awareness about the health needs of women who have served in the armed forces.

"Beyond the Camouflage: Uncovering the Health Needs of Women Veterans" will focus on - and celebrate - the nearly 2 million women veterans and 230,000 women deployed to Iraq and Afghanistan."

05.06.11 | By Kate Connors

A recent study in the Journal of the American Medical Association raises notable points about the current presence of comparative effectiveness research (CER) in the health care system.

Excluding orphan drugs and first-in-class medicines, a majority of new medicines (defined as new molecular entities) approved by the FDA between 2000 and 2010 had CER data available at the time of approval.

05.05.11 | By Kate Connors

Andrew Sullivan, in The Daily Beast, directed my attention to an opinion piece on The New York Times's Opinionator blog about "the science gap" - in other words, how evolving science is changing the research landscape. Sullivan featured a quote from Stanford University's Dr.

05.05.11

With the debate over the future of Medicare heating up, there are two interesting recent opinion pieces worth taking a look at.

The first by Former HHS Secretary and Governor of Wisconsin Tommy Thompson and Donald Crand, President & CEO of the California Association of Physician Groups (CAPG) in the Huffington Post.

05.04.11 | By Kate Connors

An article in today's Boston Globe refers to biopharmaceutical research companies "dedicating more resources to rare disorders, illnesses that are prevalent in the developing world, and medical conditions that affect minority populations in rich countries."

05.03.11

The devastation caused by the string of tornadoes and storms continues to be felt. We've already blogged a couple of times on what Rx Response is doing to assist state and local emergency managers. But circumstances call for additional help for many of the region's uninsured patients, and the Partnership for Prescription Assistance is also stepping in to help.

05.03.11 | By Kate Connors

For years, PhRMA has supported several programs that educate consumers about the safe disposal of expired and unused medications, including SMARxT Disposal, American Medicine Chest Challenge, and most recently, the DEA National Take Back Day, which occurred April 30 at approved locations across the nation.

05.02.11 | By Erin Mullen

As a result of the string of deadly tornadoes that have ravaged the Southeast United States, Rx Response began immediately monitoring the storms' impact on the flow of medicine in the affected areas and has elevated its engagement status from Stand-By to Alert.

04.29.11

Responding to the wave of storms and storm-related damage and injuries across the Southern United States, Rx Response, as part of its situation monitoring effort, has initiated Pharmacy Status Reporting within the following states affected by the severe tornadoes in the southeast:

Pages